Cosmax Pharma Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.27 Cr
About Cosmax Pharma Llp
Cosmax Pharma Llp (CPL) is 9 Year, 3 Months old Limited Liability Partnership 19 November 2015. Its registered office is in South West Delhi, Delhi, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAF-1873
- Incorporation Date
19 Nov 2015
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Delhi
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Cosmax Pharma Llp?
Designated Partners (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suraj Sharma  | Designated Partner | 01-Apr-2017 | Current |
| Manish Garg | Designated Partner | 01-Apr-2017 | Current |
| Sanjay Gupta | Designated Partner | 19-Nov-2015 | Current |
| Rajat Gupta | Designated Partner | 16-May-2016 | Current |
Financial Performance of Cosmax Pharma Llp.
Enhance accessibility to Cosmax Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cosmax Pharma Llp?
Unlock access to Cosmax Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Glensmith Labs Private LimitedSanjay Gupta and Manish Garg are mutual person
Skymap Packaging Private LimitedSanjay Gupta is a mutual person
- Skymap Lifesciences Private Limited
Sanjay Gupta is a mutual person
- Skymap Pharmaceuticals Private Limited
Sanjay Gupta and Manish Garg are mutual person
- Skymap Welfare Foundation
Sanjay Gupta and Manish Garg are mutual person
Mks Healthcare LlpSanjay Gupta is a mutual person
Charges (Loans)
₹52.70 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 5.27 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Mar 2017 | Hdfc Bank Limited | ₹5.27 Cr | Open |
How Many Employees Work at Cosmax Pharma Llp?
Cosmax Pharma Llp has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosmax Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosmax Pharma Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.